Cy3 Goat Anti-Human IgG (H+L) Antibody: Empowering Advanced Immunoassays with Signal Amplification

Principle and Setup: The Science Behind Cy3-Conjugated Secondary Antibody Performance

The Cy3 Goat Anti-Human IgG (H+L) Antibody from APExBIO is a polyclonal secondary antibody specifically engineered for the sensitive detection of human immunoglobulins (IgG, heavy and light chains). By conjugating the antibody to Cy3—a high-quantum yield dye with excitation at 552 nm and emission at 565 nm—this reagent transforms immunoassays with striking fluorescent intensity and enhanced signal-to-noise ratio.

Affinity-purified from goat serum immunized with pooled human IgG, the antibody undergoes immunoaffinity chromatography, ensuring high specificity and minimal cross-reactivity. The Cy3 label is covalently linked to preserve antibody affinity while enabling direct fluorescence-based readouts. The antibody is supplied at 1 mg/mL in a stabilizing buffer and is designed for robust performance in immunofluorescence assays (ICC/IF), immunohistochemistry (IHC on frozen and paraffin sections), flow cytometry, and ELISA.

• Key features: High specificity for human IgG (H+L), minimal cross-reactivity, high quantum yield Cy3 dye, compatible with multiplexing and automation.
• Storage and stability: Stable for 12 months at -20°C, avoid repeated freeze-thaw cycles, protect from light to maintain fluorescent integrity.

Step-by-Step Workflow: Optimized Protocols for Cy3 Goat Anti-Human IgG (H+L) Antibody

Immunofluorescence Assay (ICC/IF)

1. Sample Preparation: Fix cultured cells with 4% paraformaldehyde, permeabilize with 0.1% Triton X-100 if intracellular antigens are targeted.
2. Blocking: Incubate with 1% BSA in PBS to minimize non-specific binding.
3. Primary Antibody Incubation: Add human IgG-specific primary antibody at recommended dilution for 1 hour at room temperature.
4. Secondary Antibody Incubation: Dilute Cy3 Goat Anti-Human IgG (H+L) Antibody (typically 1:500–1:1,000 in PBS with 1% BSA), incubate 1 hour in the dark.
5. Washing: Rinse three times with PBS to remove unbound antibody.
6. Mounting and Imaging: Mount with antifade medium, image using fluorescence microscope (excitation 552 nm, emission 565 nm).

In published performance assessments (see review), this workflow yields a 3–5x improvement in signal intensity compared to non-conjugated secondary antibodies, with signal-to-background ratios exceeding 15:1 in typical ICC settings.

Immunohistochemistry (IHC) on Frozen and Paraffin-Embedded Sections

1. Deparaffinize and rehydrate tissue sections (for IHC-P), or equilibrate frozen sections to room temperature.
2. Antigen retrieval (if necessary): Heat-induced epitope retrieval in citrate buffer, 10–20 minutes at 95°C.
3. Block with 1% BSA in PBS.
4. Primary antibody incubation (human IgG-specific).
5. Incubate with Cy3 Goat Anti-Human IgG (H+L) Antibody (1:200–1:500), protected from light.
6. Wash and mount as above; image using a fluorescence microscope.

Quantified results indicate robust staining with sharp contrast and minimal tissue autofluorescence interference, as highlighted in independent validations.

Flow Cytometry Protocol

1. Harvest and wash cells with cold PBS containing 1% BSA.
2. Block Fc receptors (if needed) to reduce non-specific binding.
3. Stain with primary human IgG antibody for 30 minutes at 4°C.
4. Wash and incubate with Cy3 Goat Anti-Human IgG (H+L) Antibody (1:100–1:500, 30 minutes, in the dark).
5. Wash and resuspend in PBS; analyze promptly by flow cytometer using appropriate channels for Cy3.

This reagent consistently delivers high mean fluorescence intensity (MFI) shifts, enabling sensitive detection of human IgG+ cells even in complex samples, as detailed in the comparative review.

ELISA Enhancement

1. Coat plates with capture antibody; block with 1% BSA.
2. Add antigen and human IgG primary antibody.
3. Apply Cy3 Goat Anti-Human IgG (H+L) Antibody (1:1,000–1:5,000) for 1 hour at room temperature.
4. Wash and detect using a fluorescence plate reader (excitation/emission: 552/565 nm).

Fluorescent detection with Cy3 enables quantitative analysis down to picogram levels, outperforming conventional HRP-based colorimetric detection in sensitivity by 2–3 fold.

Advanced Applications and Comparative Advantages

Multiplex Immunoassays and Translational Research

The Cy3 Goat Anti-Human IgG (H+L) Antibody is a cornerstone for multiplexed immunofluorescence, where simultaneous detection of multiple targets is essential. Its narrow excitation/emission spectrum allows parallel use with other fluorophores, supporting advanced imaging and high-dimensional flow cytometry. This capability is crucial for studies like orthopoxvirus antibody characterization, where dissecting the immune repertoire requires precise, multiplexed detection (Zhao et al., 2025).

When used in translational research or diagnostics, the robust signal amplification provided by this fluorescent secondary antibody for human IgG detection minimizes false negatives and enables accurate quantification even in low-abundance targets. This is especially valuable in infectious disease surveillance, autoimmunity profiling, and antibody screening platforms.

Comparative Review and Resource Interlinking

• "Cy3 Goat Anti-Human IgG (H+L) Antibody: Precision in Human IgG Detection": Complements this article by providing quantitative comparisons of signal-to-noise ratios and specificity across different immunoassay platforms.
• "Cy3 Goat Anti-Human IgG (H+L) Antibody: Enabling Precision in Immunofluorescence": Extends the discussion into emerging infectious disease research and highlights unique technical innovations relevant to pandemic response workflows.
• "Unraveling Quantitative Precision in Immunoassays": Contrasts with this guide by focusing on quantitative multiplexing and the antibody's role in next-generation diagnostic development.

Troubleshooting and Optimization Tips

• Weak or No Signal: Verify primary antibody reactivity and optimize secondary antibody dilution (start with 1:500, titrate as needed). Confirm that the Cy3-conjugated secondary antibody is protected from light at all times to prevent photobleaching.
• High Background: Extend blocking time or increase BSA concentration to 3%. Use additional washing steps and ensure the absence of endogenous fluorescence in tissue or cell samples.
• Non-specific Staining: Include species-matched serum in the blocking buffer; reduce incubation time with secondary antibody if needed.
• Photobleaching: Minimize light exposure during incubations and imaging; use antifade mounting medium for microscopy.
• Reagent Stability: Aliquot upon arrival and store at -20°C for long-term use; avoid repeated freeze-thaw cycles (up to 12 months stability at -20°C).
• Multiplexing Considerations: Choose secondary antibodies with non-overlapping fluorophores and verify filter sets to ensure spectral separation for multiplex panels.

Optimized workflows and troubleshooting tips from the performance benchmarks can guide users to achieve consistent, high-fidelity results.

Future Outlook: Next-Generation Human Immunoglobulin Detection

The evolution of antibody-based detection platforms—spanning single-cell proteomics, spatial transcriptomics, and high-throughput screening—demands secondary reagents that deliver both sensitivity and reliability. The Cy3 Goat Anti-Human IgG (H+L) Antibody is uniquely positioned to address these needs, especially as emerging infectious diseases, such as mpox and orthopoxvirus outbreaks, call for rapid, quantitative immune profiling (Zhao et al., 2025).

In the context of bispecific antibody development and epitope mapping, as demonstrated in recent orthopoxvirus research, robust secondary reagents underpin both discovery and translational phases. With further innovations in dye chemistry and antibody engineering, future iterations may offer even higher multiplexing capacity and improved photostability, supporting the next wave of precision diagnostics and therapeutic monitoring.

For researchers seeking reliable, high-performance fluorescent secondary antibodies for human IgG detection, APExBIO’s Cy3 Goat Anti-Human IgG (H+L) Antibody remains a trusted solution, enabling breakthroughs in both basic and translational immunology.